Skip to main content
. 2016 Feb 22;6(2):e010003. doi: 10.1136/bmjopen-2015-010003

Table 2.

Other clinically relevant outcomes

Outcome Number of studies Number of patients RR CI WMD CI
Patients who did not revisit hospital 4 5314 1.10* (1.03 to 1.17)†
Hospital stay (after readmission) 2 803 −0.57 (−5.32 to 4.17)‡
Readmission per patient 3 1370 −0.12 (−0.24 to 0.01)‡
ED visit per patient 2 4342 −0.15 (−0.53 to 0.23)‡
Patients with ADE 3 1401 0.94 (0.75 to 1.20)‡

*RR is >1 when the intervention increased the number of patients who did not revisit the hospital (ie, it showed success).

†p<0.01.

‡p>0.05.

ADE, adverse drug event; ED, emergency department; RR, risk ratio; WMD, weighted mean difference.